{"id":4206,"date":"2025-09-02T15:37:54","date_gmt":"2025-09-02T12:37:54","guid":{"rendered":"https:\/\/ophthalmogen.com\/?p=4206"},"modified":"2025-10-21T01:08:40","modified_gmt":"2025-10-20T22:08:40","slug":"chalazio-dislipidemia-therapeia-prolipsi","status":"publish","type":"post","link":"https:\/\/ophthalmogen.com\/en\/2025\/09\/02\/chalazio-dislipidemia-therapeia-prolipsi\/","title":{"rendered":"Chalazion in Patients with Dyslipidemia \u2013 Why It Occurs More Often and How to Manage It"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Introduction<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dyslipidemia \u2013 the abnormal levels of lipids in the blood (high cholesterol, elevated triglycerides, low HDL) \u2013 does not only affect the heart and blood vessels. It also impacts the skin, the Meibomian Glands, and ocular health.<\/p>

One of the common problems seen in these patients is chalazion, a chronic inflammatory cyst on the eyelids. In people with dyslipidemia, chalazion is more frequent, more resistant, and more likely to recur.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Why Do Patients with Dyslipidemia Have Increased Risk of Chalazion?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  1. Thicker Meibomian Secretion<\/strong><\/li><\/ol>

    High cholesterol and triglycerides alter the composition of the Meibomian Gland secretions. The meibum becomes thicker and stickier, blocking the gland orifices and leading to chalazion formation.<\/p>

    1. Pro-Inflammatory Microenvironment<\/strong><\/li><\/ol>

      Dyslipidemia promotes chronic low-grade systemic inflammation. This inflammatory background extends to the eyelids, increasing the likelihood of inflammation and chalazia.<\/p>

      1. Link with Metabolic Syndrome<\/strong><\/li><\/ol>

        Many patients with dyslipidemia also present features of metabolic syndrome (obesity, hypertension, diabetes), adding further burden to ocular health.<\/p>

        1. Slower Healing<\/strong><\/li><\/ol>

          In dyslipidemic individuals, tissues heal more slowly, meaning a chalazion may last longer and be more stubborn.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

          \n\t\t\t
          \n\t\t\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
          \n\t\t\t\t\t\t
          \n\t\t\t\t\t
          \n\t\t\t
          \n\t\t\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
          \n\t\t\t
          \n\t\t\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t

          Statistics<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t\t\t\t\t